Muscle weakness is one of the biggest challenges of aging. As people get older, they naturally lose muscle strength and muscle mass, a condition known as sarcopenia. This can make everyday activities like climbing stairs, carrying groceries, or getting up from a chair much more difficult. While exercise and good nutrition remain the best ways to slow muscle loss, researchers are searching for new treatments that target the underlying causes of age-related muscle weakness.
A new study that is based on evaluating sarcopenia in humans and new mechanisms in animals suggests that scientists may have discovered new causes. Instead of finding that aging muscles simply become smaller or weaker, the researchers found that the connection between nerves and muscles begins to fail. Even more encouraging, they were able to improve muscle function in older animals by targeting this problem, opening the door to a possible future treatment for sarcopenia.
What Is Sarcopenia?
Sarcopenia is the gradual loss of muscle strength and muscle mass that happens with aging.
It can make it harder to:
- Walk long distances
- Climb stairs
- Lift everyday objects
- Maintain balance
- Stay independent
While losing some muscle is a normal part of aging, not everyone develops severe sarcopenia. Scientists have been trying to understand why some older adults lose much more strength than others.Â
What Did the Researchers Discover?
Every time you move, your brain sends a signal through a nerve to your muscles. That signal crosses a tiny connection called the neuromuscular junction, or NMJ.
Think of the NMJ as the plug connecting a lamp to an electrical outlet. If the plug becomes loose, electricity cannot flow properly—even if both the lamp and the outlet still work.
The researchers found that many older adults with muscle weakness had problems transmitting signals across the neuromuscular junction. The more severe the communication problem, the weaker the person’s muscles tended to be. Similar changes were also found in older mice and rats. Junior Chamber International
Why Does This Happen?
The team discovered that aging muscles had lower amounts of a protein called NaV1.4 at the neuromuscular junction.
NaV1.4 acts like an electrical switch that helps muscle fibers respond when they receive a signal from a nerve.
When NaV1.4 levels dropped:
- Muscle fibers became less responsive.
- Nerve signals were more likely to fail.
- Muscles produced less force.
The researchers even blocked NaV1.4 in healthy adult rats and recreated many of the same communication problems seen in aging muscles, suggesting this loss may play an important role in sarcopenia.Â
Could This Lead to a New Treatment?
The researchers tested a compound that blocks a protein called ClC-1, which helps control how easily muscle cells become activated.
In older rodents, blocking ClC-1:
- Improved communication between nerves and muscles.
- Increased muscle excitability.
- Improved muscle strength and function.
These findings suggest that improving communication at the neuromuscular junction may become a new way to treat age-related muscle weakness instead of focusing only on building muscle mass. However, this treatment has not yet been proven to work in people and will need to be tested in future clinical trials.
What This Means for You
This study offers a new way of thinking about sarcopenia. Instead of viewing muscle weakness as simply a problem of losing muscle, researchers found that aging may also disrupt the electrical communication between nerves and muscles.
Although more research is needed before this approach can become a treatment, the findings suggest that restoring this communication could one day help older adults maintain strength, mobility, and independence for longer.
Source
- Arnold WD, Morgen JJ, Thomasen PB, et al. Neuromuscular junction failure in sarcopenia is linked to NaV1.4 loss and reversed by ClC-1 inhibition. J Clin Invest. 2026;136(17):e190646. Accessed by: https://www.jci.org/articles/view/190646.
